15 N-Leucine Single-Administration Method for Measuring Endogenous Amino Acid Losses in Chicken:Optimization of Main Parameters

HU Rujiu,WANG Fei,LI Jing,YAO Junhu,YANG Xiaojun
DOI: https://doi.org/10.3969/j.issn.1006-267x.2015.10.009
2015-01-01
Abstract:The current study was conducted to optimize parameters of the 15 N-leucine single-administration method for measuring endogenous amino acid losses in chicken. Experiment 1 was designed to provide suitable parameters of gas chromatography-mass spectrometry ( GC-MS ) for determing 15 N-enrichment of leucine (APEL) and ascertain an appropriate scope of APEL in samples. Experiment 2 was carried out to optimize ad-ministration parameters of 15 N-leucine, using 48 Avian roosters to study the effects of administration methods (intramuscular injection and intravenous injection) and doses (10, 20 and 30 mg/kg BW) of 15N-leucine on 15 N-enrichment in main secretory sources of endogenous amino acids. The results showed as follows: 1 ) the biggest characteristic fragment ion peaks of MTBSTFA derivatives of leucine in GC-MS is m/z=200. Precision and accuracy of measurement were poor when APEL<0.1% in samples; measurement precision and accuracy respectively ranged from 4.3% to 9.7% and -5.9% to 4.1% when APEL ranged from 0.1% to 3.2%, and the standard curve of mixtures of natural and 15N-leucine showed a good linear relationship (R2=0.989). 2) The values of APEL in main secretory sources of endogenous amino acids were greater than 0.1% for 15N-leucine administration doses of 20 and 30 mg/kg BW. The experimental birds administrated 15N-leucine through intra-venous injection showed harmful stress including congestion and extravasation at the injection sites. 3 ) There were not administration methods and doses interaction effects ( P>0.05) of APEL in main secretory sources of endogenous amino acids. The values of APEL in main secretory sources of endogenous amino acids were in-creased significantly (P<0.05) with an increase of administration dose. The values of APEL among different secretory sources had no significant difference (P>0.05) at 15N-leucine administration doses of 20 mg/kg BW. However, the values of APEL in pancreas and intestinal mucosa were influenced significantly (P<0.05) by 15 N-leucine administration method. In conclusion, the 15 N-leucine administration doses of 20 mg/kg BW is se-lected to meet the requirements of GC-MS analysis, and intramuscular injection of 15 N-leucine is applied to re-duce harmful stress, simplify the operating procedure and reduce the cost.
What problem does this paper attempt to address?